ArticleSmall science2025
Mechanically Tunable Biofabricated Channels Enable Mimicking Arterial Pulsatility and Dynamic Tissue Actuation.
Article in Small science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dynamic alteration of blood vessel geometry is an inherent feature of the circulatory system. However, while the engineering of multiscale, branched, and interconnected blood vessels has been well explored, mimicking the dynamic behavior (e.g., pulsatile blood flow) of native arterial vessels has remained understudied. This is surprising because the natural pulsatile flow and subsequent dynamic deformation of arteries provide physiologically relevant mechanical actuation to proximal cells and tissues, contributing to both tissue homeostasis and disease progression. Yet, many tissue engineering efforts and Organ-on-Chip developments have focused on replicating vessel structure, while overlooking the native mechanical dynamicity that governs arterial tissue function. Here, the development of an on-demand tunable elastic hydrogel is reported, composed of tyramine-conjugated alginate, offering controlled, reversible dilation under physiologically relevant flow. Exploring casted and 3D bioprinted channels, how vessel dilation influences shear stresses in relation to vessel compliance is investigated. This approach is demonstrated to allow for hydrodynamic mechanodeformation and stimulation of engineered tissues. Moreover, it is revealed that pulsatile flow deformation alters compound penetration rates (e.g., nutrients and pharmaceuticals) into surrounding tissues. Finally, the spatially controlled stiffening of engineered blood vessels is demonstrated to locally limit the dilation, modeling blood vessel diseases such as stenosis or aneurysm.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.